apollo
0
48 Hrs returnable
COD available

Online payment accepted

Prescription drug

Whats That

tooltip
ADALIMUMAB-40MG
PARENTERAL
Not Returnable
Apr-24
Prescription drug
 Trailing icon

Country of origin

India
Other Info - ADL0022

FAQs

Adlumab 40mg Injection 0.8 ml contains Adalimumab, which works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive.
Adlumab 40mg Injection 0.8 ml affects your immune system and makes you more susceptible to infections. Hence, it is not recommended in people with active infections like tuberculosis or abnormal liver enzymes. Adlumab 40mg Injection 0.8 ml can also increase the risk of developing cancers; hence, informing your doctor if you have a history of any cancer is essential.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
bannner image

Alcohol

Consult your doctor

It is not known if alcohol interacts with Adlumab 40mg Injection 0.8 ml. Please consult the doctor.

bannner image

Pregnancy

Caution

If you are pregnant or planning pregnancy, inform your doctor before receiving Adlumab 40mg Injection 0.8 ml. Your doctor may prescribe this medicine if the benefits outweigh the risks.

bannner image

Breast Feeding

Caution

If you are breastfeeding, inform your doctor before receiving Adlumab 40mg Injection 0.8 ml.

bannner image

Driving

Not applicable

Adlumab 40mg Injection 0.8 ml will be administered in the hospital setting. Hence, driving is not recommended.

bannner image

Liver

Caution

Adlumab 40mg Injection 0.8 ml should be used with caution if you have liver disease. Dose adjustment may be needed in patients with liver impairment.

bannner image

Kidney

Caution

Adlumab 40mg Injection 0.8 ml should be used with caution if you have kidney disease. Dose adjustment may be needed in patients with liver impairment.

bannner image

Children

Caution

Adlumab 40mg Injection 0.8 ml is not recommended in children below two years of age as safety and efficacy are not established. In children above two years of age, it will be administered by the pediatrician. Adlumab 40mg Injection 0.8 ml is used in children only for the treatment of juvenile idiopathic arthritis, paediatric Crohn’s disease, and uveitis.

About Adlumab 40mg Injection 0.8 ml

Adlumab 40mg Injection 0.8 ml belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors that help reduce signs and symptoms of autoimmune disorders. It is primarily used in the treatment of rheumatoid arthritis, ankylosing spondylitis, juvenile idiopathic arthritis, plaque psoriasis, and psoriatic arthritis. This medicine is also used in the treatment of Crohn’s disease, ulcerative colitis, hidradenitis suppurativa, and uveitis.

Adlumab 40mg Injection 0.8 ml consists of Adalimumab, which works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain caused by various autoimmune diseases.

Adlumab 40mg Injection 0.8 ml may cause certain side effects such as nausea, headache, back pain, upper respiratory tract infections, vision problems, dizziness, pale skin, numbness, chest pain, rash, and injection site reactions. Most of these side effects do not require medical attention or resolve over time. However, if these side effects persist for longer, please consult your doctor on priority. Adlumab 40mg Injection 0.8 ml is a parenteral medicine. It will be administered by a trained healthcare doctor. Hence, do not self-administer. Your physician will decide the dose and duration of the medicine based on the type and severity of the condition.

Adlumab 40mg Injection 0.8 ml should be avoided if you are allergic to any of its components.  Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, hepatitis B virus infection, heart failure, liver, heart, or kidney diseases, or a weak immune system, as it can worsen your health condition. Adlumab 40mg Injection 0.8 ml may cause dizziness, so drive only if you are alert and focused. Adlumab 40mg Injection 0.8 ml should not be given to children under two years of age as safety has not been established. Consult the doctor if you are pregnant or breastfeeding.

Uses of Adlumab 40mg Injection 0.8 ml

Rheumatoid arthritis, Ankylosing spondylitis, Psoriatic arthritis, Plaque psoriasis, Crohn’s disease, Uveitis, Ulcerative colitis.

Medicinal Benefits Mweb

Medicinal Benefits

Adlumab 40mg Injection 0.8 ml consists of Adalimumab, which belongs to the class of monoclonal TNF (Tumor necrosis factor) inhibitors. It works by inhibiting the TNF-α and TNF-β binding to the cell surface, thereby making the TNF cytokine inactive. This helps reduce inflammation and pain, redness, and inflammation (swelling) caused by various autoimmune diseases.

Directions for Use

Adlumab 40mg Injection 0.8 ml will be administered by a healthcare professional. Do not self-administer.

Side Effects of Adlumab 40mg Injection 0.8 ml

  • Tingling or numbness
  • Shortness of breath
  • Vision problems
  • Injection site reactions
  • Headache
  • Nausea
  • Upper respiratory tract infections.
  • Chest pain

Drug Warnings

Adlumab 40mg Injection 0.8 ml should be avoided if allergic to it or any other components present. Inform your doctor if you have any history of serious infections, tuberculosis, optimistic infections, cancer, alcoholic hepatitis, hepatitis B virus infection, heart failure, liver, heart or kidney diseases, weak immune system, multiple sclerosis (nerve and muscle disease), or diabetes as it can worsen your health condition. Do not take live vaccines while being treated with Adlumab 40mg Injection 0.8 ml to prevent any serious consequences. Adlumab 40mg Injection 0.8 ml is not recommended for use in children below two years of age as safety and efficacy are not established. This medicine is not recommended for patients suffering from sepsis as it can worsen the condition.

Drug-Drug Interactions

verifiedApollotooltip
AdalimumabDexamethasone
Severe
AdalimumabCarfilzomib
Severe

Drug-Food Interactions

verifiedApollotooltip
No Drug - Food interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Diseases Interactions

verifiedApollotooltip
No Drug - Disease interactions found in our database. Some may be unknown. Consult your doctor for what to avoid during medication.

Drug-Drug Interactions Checker List

  • CERTOLIZUMAB
  • GOLIMUMAB
  • INFLIXIMAB
  • RITUXIMAB
  • ANAKINRA
  • ABATACEPT

Habit Forming

No

Special Advise

  • It is advised to closely monitor the patient for infections like active tuberculosis during and after the treatment, though the patient gets a negative tuberculin test.
  • It is essential to inform your doctor if you have any active viral, bacterial, and fungal infections before starting Adlumab 40mg Injection 0.8 ml.

Diet & Lifestyle Advise

  • Exercising regularly helps in muscle stretching that is less likely to spasm, tear and sprain. Mild exercises such as jogging and walking are helpful for muscle stretching.
  • Massages can also be helpful.
  • Avoid freezing and hot temperatures.
  • Avoid wearing tight-fitting clothes; instead, wear loose garments.
  • Rest well and get plenty of sleep.
  • Stay hydrated; drink plenty of water.